Uncategorized
Clearside granted fourth U.S. patent for microneedle drug delivery methods, devices
The U.S. Patent and Trademark Office has granted a fourth patent to Clearside Biomedical for its proprietary microneedle drug delivery methods and devices, according to a Clearside press release.The patent, “Methods and Devices for Drug Delivery to Ocular Tissue Using Microneedle,” provides exclusivity for the administration of any drug to a patient’s eye by inserting a hollow microneedle into the eye and infusing the drug into the suprachoroidal space.